The National Health Commission said in a notice released on Tuesday that it has recently learned that some medical ...

Higher education appeared to protect against tau accumulation during the amyloid-negative stages of Alzheimer's disease but ...

Alzheimer's disease, which is a neurodegenerative disease that affects ... The fastest growth in older populations is ...

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest pharma market. The National Medical ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment "We are confident that this ...

The 43,000 sq m facility – roughly the size of six football fields – features spaces that replicate familiar settings like a ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

The facility gives residents more choice and autonomy in daily living. Read more at straitstimes.com. Read more at ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment INDIANAPOLIS, ...